HomeCGEM • NASDAQ
add
Cullinan Therapeutics Inc
Previous close
$17.30
Day range
$17.28 - $17.72
Year range
$7.68 - $30.19
Market cap
1.01B USD
Avg Volume
640.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 50.03M | 33.03% |
Net income | -42.03M | -30.47% |
Net profit margin | — | — |
Earnings per share | -0.75 | 8.54% |
EBITDA | -49.95M | -33.11% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 662.50M | 34.71% |
Total assets | 681.22M | 30.51% |
Total liabilities | 25.00M | 11.54% |
Total equity | 656.22M | — |
Shares outstanding | 57.98M | — |
Price to book | 1.53 | — |
Return on assets | -22.12% | — |
Return on capital | -22.99% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -42.03M | -30.47% |
Cash from operations | -36.29M | -17.05% |
Cash from investing | -185.11M | -1,628.59% |
Cash from financing | 262.20M | 579.23% |
Net change in cash | 40.79M | 107.01% |
Free cash flow | -21.59M | -6.41% |
About
Founded
2016
Website
Employees
85
